Are ob patients at risk for MRSA?
The rate of nares colonization with methicillin-resistant Staphylococcus aureus (MRSA) is low in obstetric populations, according to two presentations at this year's annual IDSOG meeting. Although the rate of MRSA colonization is estimated to be 6% to 8% in new hospital admissions, the rate of colonization in obstetric populations was 2% in both studies, performed by Dr. Mara Dinsmoor at Evanston Hospital in Evanston, Ill. and by Dr. Richard Beigi at Cleveland Metro Health Center in Cleveland, Ohio. The study from Illinois reported that over 50% of the colonized mothers had risk factors for MRSA colonization. There was one case of MRSA sepsis in a neonate born to a colonized woman, but the two strains of MRSA were genetically distinct, arguing against vertical transmission from mother to baby.
The rate of nares colonization with methicillin-resistant Staphylococcus aureus (MRSA) is low in obstetric populations, according to two presentations at this year's annual IDSOG meeting. Although the rate of MRSA colonization is estimated to be 6% to 8% in new hospital admissions, the rate of colonization in obstetric populations was 2% in both studies, performed by Dr. Mara Dinsmoor at Evanston Hospital in Evanston, Ill. and by Dr. Richard Beigi at Cleveland Metro Health Center in Cleveland, Ohio. The study from Illinois reported that over 50% of the colonized mothers had risk factors for MRSA colonization. There was one case of MRSA sepsis in a neonate born to a colonized woman, but the two strains of MRSA were genetically distinct, arguing against vertical transmission from mother to baby.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More
